Legend Biotech Corp (LEGN)
45.25
-0.16
(-0.35%)
USD |
NASDAQ |
May 06, 16:00
45.25
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Revenue (TTM): 285.14M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 285.14M |
| September 30, 2023 | 233.31M |
| June 30, 2023 | 164.66M |
| March 31, 2023 | 103.30M |
| December 31, 2022 | 117.00M |
| September 30, 2022 | 107.40M |
| June 30, 2022 | 96.92M |
| March 31, 2022 | 118.87M |
| December 31, 2021 |
| Date | Value |
|---|---|
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 75.00M |
| September 30, 2020 | 54.34M |
| June 30, 2020 | 60.27M |
| March 31, 2020 | 58.76M |
| December 31, 2019 | 57.26M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
54.34M
Minimum
Sep 2020
285.14M
Maximum
Dec 2023
117.86M
Average
103.30M
Median
Mar 2023
Revenue (TTM) Benchmarks
| Johnson & Johnson | 89.66B |
| Bristol-Myers Squibb Co | 45.53B |
| 2seventy bio Inc | 100.39M |
| Exelixis Inc | 1.847B |
| Alnylam Pharmaceuticals Inc | 2.003B |